Boston Common Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $895K | Sell |
|
|||||
|
2023
Q3 | $876K | Sell |
|
|||||
|
2023
Q2 | $1.06M | Hold |
|
|||||
|
2023
Q1 | $1.06M | Buy |
|
|||||
|
2022
Q4 | $1.05M | Hold |
|
|||||
|
2022
Q3 | $876K | Buy |
|
|||||
|
2022
Q2 | $1.33M | Buy |
|
|||||
|
2022
Q1 | $1.1M | Buy |
|
|||||
|
2021
Q4 | $1.12M | Sell |
|
|||||
|
2021
Q3 | $970K | Sell |
|
|||||
|
2021
Q2 | $30.6M | Buy |
|
|||||
|
2021
Q1 | $27M | Buy |
|
|||||
|
2020
Q4 | $24.6M | Buy |
|
|||||
|
2020
Q3 | $24.6M | Buy |
|
|||||
|
2020
Q2 | $25.6M | Buy |
|
|||||
|
2020
Q1 | $22.1M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $424K | Hold |
|
|||||
|
2017
Q2 | $450K | Hold |
|
|||||
|
2017
Q1 | $440K | Sell |
|
|||||
|
2016
Q4 | $495K | Hold |
|
|||||
|
2016
Q3 | $555K | Sell |
|
|||||
|
2016
Q2 | $614K | Sell |
|
|||||
|
2016
Q1 | $4.82M | Sell |
|
|||||
|
2015
Q4 | $5.09M | Sell |
|
|||||
|
2015
Q3 | $5.49M | Sell |
|
|||||
|
2015
Q2 | $6.13M | Sell |
|
|||||
|
2015
Q1 | $7.04M | Sell |
|
|||||
|
2014
Q4 | $6.57M | Buy |
|
|||||
|
2014
Q3 | $7M | Buy |
|
|||||
|
2014
Q2 | $7.75M | Sell |
|
|||||
|
2014
Q1 | $7.83M | Sell |
|
|||||
|
2013
Q4 | $8.28M | Buy |
|
|||||
|
2013
Q3 | $6.5M | Sell |
|
|||||
|
2013
Q2 | $6.72M | Buy |
|